Overdosage is characterised by nausea, agitation and restlessness, dryness of the mouth, dizziness and tremor. In gross overdosage the above symptoms may also be associated with dyspnoea, tachycardia, disorientation and convulsions.
Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the drug tend to rapidly develop tolerance and escalate their dose. Fencamfamin is used for treating depressive day-time fatigue, lack of concentration and lethargy. It is especially useful in patients with chronic conditions due to its favourable safety profile.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Hydrocodone | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Magnesium sulfate | The therapeutic efficacy of Fencamfamin can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Fencamfamin may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Mirtazapine | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Orphenadrine | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Pramipexole | Fencamfamin may increase the sedative activities of Pramipexole. |
| Ropinirole | Fencamfamin may increase the sedative activities of Ropinirole. |
| Rotigotine | Fencamfamin may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Fencamfamin. |
| Sodium oxybate | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Thalidomide | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Fencamfamin. |
| Ethanol | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Fencamfamin may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Zimelidine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Fencamfamin. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Fencamfamin. |
| Zopiclone | The risk or severity of adverse effects can be increased when Fencamfamin is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Fencamfamin. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Fencamfamin. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fencamfamin. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Fencamfamin. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Fencamfamin. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Fencamfamin. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Fencamfamin. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Fencamfamin. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Fencamfamin. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Fencamfamin. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Fencamfamin. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Fencamfamin. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Fencamfamin. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Fencamfamin. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Fencamfamin. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Fencamfamin. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Fencamfamin. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Fencamfamin. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Fencamfamin. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Fencamfamin. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Fencamfamin. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Fencamfamin. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Fencamfamin. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Fencamfamin. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Fencamfamin. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Fencamfamin. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Fencamfamin. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Fencamfamin. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Fencamfamin. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Fencamfamin. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Fencamfamin. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Fencamfamin. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Fencamfamin. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Fencamfamin. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Fencamfamin. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Fencamfamin. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Fencamfamin. |
| Gallamine triethiodide | The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Fencamfamin. |
| Entacapone | The risk or severity of CNS depression can be increased when Entacapone is combined with Fencamfamin. |
| Oxycodone | The risk or severity of CNS depression can be increased when Oxycodone is combined with Fencamfamin. |
| Dextromethorphan | The risk or severity of CNS depression can be increased when Dextromethorphan is combined with Fencamfamin. |
| Mephenytoin | The risk or severity of CNS depression can be increased when Mephenytoin is combined with Fencamfamin. |
| Cisatracurium | The risk or severity of CNS depression can be increased when Cisatracurium is combined with Fencamfamin. |
| Fenfluramine | The risk or severity of CNS depression can be increased when Fenfluramine is combined with Fencamfamin. |
| Mazindol | The risk or severity of CNS depression can be increased when Mazindol is combined with Fencamfamin. |
| Fluticasone propionate | The risk or severity of CNS depression can be increased when Fluticasone propionate is combined with Fencamfamin. |
| Lisuride | The risk or severity of CNS depression can be increased when Lisuride is combined with Fencamfamin. |
| Ethosuximide | The risk or severity of CNS depression can be increased when Ethosuximide is combined with Fencamfamin. |
| Thiopental | The risk or severity of CNS depression can be increased when Thiopental is combined with Fencamfamin. |
| Cisapride | The risk or severity of CNS depression can be increased when Cisapride is combined with Fencamfamin. |
| Butorphanol | The risk or severity of CNS depression can be increased when Butorphanol is combined with Fencamfamin. |